Anupam Rasayan shares in focus on signing ₹922 crore deal with Korean MNC

Shares of Anupam Rasayan will be in focus after the company informed exchanges that it has signed a letter of intent with a Korean multi-national company. Anupam Rasayan has signed 10-year letter of intent valued at $106 million (approximately ₹922 crore) with a Korean multinational recognized for its leadership in specialty chemicals for a high-performance niche chemical expected to be supplied from FY26.

"This long-term partnership reinforces Anupam’s expertise in delivering advanced chemical solutions and strengthens its presence in high-growth global markets," the company said in a press release.

"Securing this long-term LOI with a global industry leader is a testament to our strong R&D capabilities and commitment to innovation. The specialty chemical covered under this agreement has niche applications in the aviation and electronics sectors. With our robust backward integration capabilities, we ensure a stable and efficient supply chain, offering reliability and consistency to our global customers. Expanding into South Korea adds another significant geography to Anupam Rasayan’s global presence, positioning the company for long-term growth in one of the world’s most advanced manufacturing hubs," said Gopal Agrawal, CEO of Anupam Rasayan.

Anupam Rasayan is India's leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.

Anupam Rasayan shares ended 0.94% higher at ₹787.79 on Monday, the stock has so far this year advanced 9.2% outperforming the benchmarks which are trading in the negative territory. The company in the quarter ended December 2024 reported net profit of ₹19 crore marking an increase of 27% from ₹15 crore during the same period last year.

Its revenue from operations declined marginally to ₹212 crore as against ₹215 crore in the year ago period.